ArticleBMC cancer2025
Prevalence and factors associated with high-risk human papillomavirus infection and cervical lesions among women with HIV in Addis Ababa, Ethiopia.
Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Prevalence of cervical human papillomavirus infections and cytological abnormalities in asymptomatic women living with HIV in Addis Ababa, Ethiopia.Scientific reports · 2026Article
- High-risk human papillomavirus and HBV, HCV, and T. pallidum association among women living with HIV in selected health facilities of Mekelle, Tigray, Northern Ethiopia.Scientific reports · 2026Article
- Prevalence of High-Risk Human Papillomavirus Infection and Associated Risk Factors Among Women Attending the Gynecology Unit in Bahir Dar, Northwest Ethiopia.Clinical Medicine Insights. Oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn Ethiopia, the Human Papillomavirus (HPV) type distribution is still not well characterized among women with Human Immunodeficiency Virus (HIV). This study aimed to assess the prevalence of HPV infection, determine the distribution of HPV genotypes, and examine the rate of abnormal findings from visual inspection with acetic acid (VIA) among HPV-positive women living with HIV (WWH) in Addis Ababa, Ethiopia. It also analyzed the factors associated with these findings. METHODOLOGY: A retrospective record review was conducted at 16 HPV-DNA testing health facilities in Addis Ababa, Ethiopia. A total of 3303 WWH were screened for HPV infection through self- and clinician-based cervical swab collection from April 2021 to January 2022, all were included in the study. WWH were offered HPV testing at antiretroviral therapy (ART) clinics. Trained nurses invited women positive for high-risk HPV (hrHPV) types for VIA screening. Women with suspicious lesions were referred to gynaecologic centres, and others were appointed for a follow-up visit after one year. Associations between independent variables and HPV-DNA as well as VIA positivity were assessed using Binary logistic regression.
resultThe prevalence of hrHPV infection was 28.7% (95% CI: 27.2, 30.3%). Of those, 145 (15.3%) had HPV 16, and 38 (4%) had HPV 18 and the rest larger proportion was "other high-risk HPV" accounted for 695 (73.3%). The data showed that 70 (7.4%) women had multiple hrHPV infection, meaning ≥ 2 HPV DNA types were found in a single sample. This study found that the odds of women aged 25-29 being infected with hrHPV was 68% higher than those of women aged 40-49 (Adjusted Odds Ratio (AOR) = 1.68, 95% CI 1.26, 2.22). Women who were married and widowed had lower odds of hrHPV infection as compared to divorced women. Out of 948 hrHPV-positive clients, 786 (82.9%) had a follow up VIA screening, of which 15.5% (122) were found to be VIA positive. A history of STI was significantly associated with VIA positivity (AOR = 1.69, 95% CI 1.12, 2.54).
conclusionThe prevalence of hrHPV in WWH was high as compared to other studies done in Ethiopia, particularly that of HPV 16 and "other hrHPV". Prevalence of cervical lesion based on VIA was higher as compared to other studies that did not initially screen for hrHPV infection. This underlines the need to offer screening services to WWH and further characterize the other hrHPV. Screening for cervical lesions is of particular importance in women who report a history of STIs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.